4.6 Article

Novel prognostic indicator combining inflammatory indicators and tumor markers for gastric cancer

Journal

WORLD JOURNAL OF SURGICAL ONCOLOGY
Volume 21, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s12957-023-02926-w

Keywords

Gastric cancer; Inflammatory indicators; Tumor markers; Neutrophil-to-lymphocyte ratio; Carbohydrate antigen 19-9

Ask authors/readers for more resources

This study found that the neutrophil-to-lymphocyte ratio (NLR) and CA19-9 were independent prognostic factors for gastric cancer patients. The NLR-CA19-9 score (NCS), which is a combination of the two factors, can provide more accurate predictions of the prognosis of gastric cancer patients, and its predictive value is significantly better than that of traditional inflammatory indicators or tumor markers.
BackgroundGastric cancer (GC) is one of the most common malignant tumors worldwide, and we hope to identify an economical but practical prognostic indicator. It has been reported that inflammatory indicators and tumor markers are associated with GC progression and are widely used to predict prognosis. However, existing prognostic models do not comprehensively analyze these predictors.MethodsThis study retrospectively reviewed 893 consecutive patients who underwent curative gastrectomy from January 1, 2012, to December 31, 2015, in the Second Hospital of Anhui Medical University. Prognostic factors predicting overall survival (OS) were analyzed using univariate and multivariate Cox regression analyses. Nomograms including independent prognostic factors were plotted for predicting survival.ResultsUltimately, 425 patients were enrolled in this study. Multivariate analyses demonstrated that the neutrophil-to-lymphocyte ratio (NLR, total neutrophil count/lymphocyte count x 100%) and CA19-9 were independent prognostic factors for OS (p=0.001, p=0.016). The NLR-CA19-9 score (NCS) is constructed as the combination of the NLR and CA19-9. We defined NLR<2.46 and CA19-9 <= 37 U/ml as an NCS of 0, NLR >= 2.46 or CA19-9>37 U/ml as an NCS 1, and NLR >= 2.46 and CA19-9>37 U/ml as an NCS of 2. The results showed that higher NCS was significantly associated with worse clinicopathological characteristics and OS (p<0.05). Multivariate analyses revealed that the NCS was an independent prognostic factor for OS (NCS1: p<0.001, HR=3.172, 95% CI=2.120-4.745; NCS2: p<0.001, HR=3.052, 95% CI=1.928-4.832). Compared with traditional predictive indices, the NCS had the highest AUC for a 12-month survival, a 36-month survival, a 60-month survival, and OS (AUC= 0.654, 0.730, 0.811, 0.803, respectively). The nomogram had a higher Harrell's C-index than the TNM stage alone (0.788 vs. 0.743).ConclusionsThe NCS provides more accurate predictions of the prognosis of GC patients, and its predictive value is significantly better than that of traditional inflammatory indicators or tumor markers. It is an effective complement to existing GC assessment systems.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available